The central role of thromboxane and platelet activating factor receptors in ex vivo regulation of endotoxin-induced monocyte tissue factor activity in human whole blood

Journal of Endotoxin Research

Volumn 8, Issue 4, 2002, Pages 285-293

  Eilertsen, Karl Erik ^a   Øterud, Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (2 AMINOETHYL)BENZENESULFONYL FLUORIDE; 7 [3 (4 ACETYL 3 METHOXY 2 PROPYLPHENOXY)PROPOXY] 3,4 DIHYDRO 8 PROPYL 2H 1 BENZOPYRAN 2 CARBOXYLIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ADENOSINE DIPHOSPHATE; ARGINYLGLYCYLASPARTYLSERINE; CREATINE KINASE; CREATINE PHOSPHATE; CYPROHEPTADINE; ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRONECTIN RECEPTOR; GINKGOLIDE B; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; PEFABLOC SC; PHOSPHOLIPASE A2 INHIBITOR; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; PROTEINASE INHIBITOR; SB 203347; SERINE PROTEINASE INHIBITOR; SEROTONIN ANTAGONIST; STAUROSPORINE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; THROMBOPLASTIN; THROMBOXANE; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; THROMBOXANE RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOASSAY; BLOOD ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG ACTIVITY; HUMAN; HUMAN TISSUE; INFLAMMATION; INHIBITION KINETICS; LEUKOCYTE ACTIVATION; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM;

ARACHIDONIC ACIDS; BENZOPYRANS; CREATINE KINASE; CYPROHEPTADINE; DITERPENES; ENZYME INHIBITORS; ESCHERICHIA COLI; GINKGOLIDES; HUMANS; HYDRAZINES; INDOLES; LACTONES; LIPOPOLYSACCHARIDES; MALEIMIDES; MONOCYTES; OLIGOPEPTIDES; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, THROMBOXANE; SULFONAMIDES; SULFONES; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI;

EID: 0036374571     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805102125000498     Document Type: Article

References (51)

1. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
2. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages
3. Bacterial lipopolysaccharide induces tyrosine, phosphorylation and activation of mitogen-activated protein kinases in macrophages
4. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression
5. Regulation of the tissue factor gene
6. Lipopolysaccharide induction of tissue factor in THP-1 cells involves Jun protein phosphorylation and nuclear factor kappaB nuclear translocation
7. Tissue factor expression by monocytes: Regulation and pathophysiological roles
8. The endotoxin-induced coagulant activity of human monocytes
9. Leukocyte procoagulant activity: Enhancement of production in vitro by IgG and antigen-antibody complexes
10. Endotoxin-induced tissue factor in human monocytes is dependent upon protein kinase C activation
11. Endotoxin-mediated bovine alveolar macrophage procoagulant induction is dependent on protein kinase C activation
12. Expression of tissue factor and tissue factor pathway inhibitor in monocytes in response to bacterial lipopolysaccharide and phorbolester
13. The role of tyrosine phosphorylation in lipopolysaccharide- and zymosan-induced procoagulant activity and tissue factor expression in macrophages
14. The role of arachidonic acid release and lipoxygenase pathway in lipopolysaccharide-induced thromboplastin activity in monocytes
15. Platelet activating factor causes a rapid increase in activity of prior expressed tissue factor on monocyte surface membrane
16. Arachidonic acid enhances the tissue factor expression of mononuclear cells by the cyclooxygenase-1 pathway: Beneficial effect of n-3 fatty acids
17. Effects of inhibitors of arachidonic acid metabolism on thromboplastin activity in human monocytes
18. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid
19. 12-Hydroxyeicosatetraenoic acid upregulates P-selectin-induced tissue factor activity on monocytes
20. Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis
21. Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis
22. Leukocytes, adhesive proteins and disseminated intravascular coagulation: Treatment of DIC with plasma/leukapheresis?
23. A novel biological effect of platelet factor 4 (PF4): Enhancement of LPS-induced tissue factor activity in monocytes
24. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice
25. Eicosanoids and iso-eicosanoids: Constitutive, inducible and transcellular biosynthesis in vascular disease
26. 2 and the release of arachidonic acid in human neutrophils
27. 2
28. 2
29. Sodium salicylate enhances expression of tissue factor (TF) in human adherent monocytes and in whole blood
30. Endotoxin-induced activation of the coagulation cascade in humans: Effect of acetylsalicylic acid and acetaminophen
31. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: Evidence that eicosanoids other than thromboxane contribute to atherosclerosis
32. Hypoxia primes endotoxin-induced tissue factor expression in human monocytes and endothelial cells by a PAF-dependent mechanism
33. Platelet activating factor enhancement of lipopolysaccharide-induced tissue factor activity in monocytes: Requirement of platelets and granulocytes
34. Platelet-activating factor: Receptors and signal transduction
35. Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor
36. Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor
37. Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse
38. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets
39. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor
40. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers
41. Regulation of monocyte procoagulant by chemoattractants
42. Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction
43. Tissue factor expression in monocytes: In vitro compared to ex vivo
44. 2 does not alter leukotriene formation
45. Anti-inflammatory properties of Go 6850: A selective inhibitor of protein kinase C
46. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988
47. Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate
48. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents
49. Characterization of the binding of FK633 to the platelet fibrinogen receptor
50. 4 receptor antagonist
51. 2 receptor antagonists